Treatment of acute migraine approved in the United Kingdom

Migraine affects about 10% of the population and is characterized not only by severe headache but also by nausea or vomiting and sensitivity to light. This means that migraines can be inexcusable for those who suffer from them.

Now, in the United Kingdom, a treatment for acute migraine has been approved that could benefit thousands of people, the National Institute for Health and Clinical Excellence (Nice) reported in a statement.

In this, the institute recommends the use of the drug rimagepant (also known as rimagepant). vidura and manufactured by Pfizer) for adults who suffer from chronic migraine and who have tried at least two triptans but without sufficient effective effect. These refer to a group of medicines used to treat migraine or headache. ,You can also read: Millions of Colombians suffer from severe physical pain: what does this mean?)

“This is the first and only medicine recommended by NICE that can help relieve the pain of acute migraine, and could be considered a revolutionary change in treatment,” Helen Knight, director of medicines evaluation at the institute, said in a statement. “

Knight said, migraine sufferers and their caregivers tell NICE that chronic migraine is “an invisible disability that affects all aspects of life, including work, education, finances, mental health, social activities and family.”

In addition to those described above, the authority also recommends the use of rimagepant in adults who cannot take or do not tolerate triptans, and who have tried anti-inflammatory medicines such as ibuprofen, aspirin and paracetamol to treat their pain. But they have not given enough results..

The institute also said, “Evidence from clinical trials shows that remizpant is more likely to reduce pain within two hours than placebo.” ,You may be interested in: One of the most popular nasal decongestants is not effective: FDA)

Symptoms of migraine headaches include severe headache, sensitivity to light or sound, nausea or vomiting and even difficulty getting out of bed, going up or down the stairs, etc.

According to the World Health Organization, one in seven people suffer from migraine, about 20% of women and 10% of men.

Do you want to know the latest health news? We invite you to see them in El Espectador.⚕️🩺